Søren S.
- Country
- Denmark
- Department
- Neurology
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyneuropathy: An Open-label Extension Study
- Evaluation of Subcutaneous Versus Intravenous Human Normal Immunoglobulin in Treatment-Naïve Patients with Chronic Inflammatory Demyelinating Polyneuropathy
- A Phase 2b, Multi-center, Randomized, Double-blind, Placebo controlled Study of IMVT-1402 Treatment in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Data & Insights
Has run more than one trial at 10 of 88 partner sites.
Specializations
Neuromuscular Disorders
The investigator specializes in the treatment and research of chronic inflammatory demyelinating polyneuropathy (CIDP), focusing on innovative therapeutic approaches for this autoimmune neurological condition.
- Autoimmune peripheral nerve disorders
- Demyelinating neuropathies
- Neurological immunotherapy
Their work encompasses investigation of various administration routes for immunological treatments.
Immunotherapy Innovation
Their research interests center on advancing subcutaneous immunoglobulin therapy methods, particularly exploring alternatives to traditional intravenous treatments for neurological conditions.
- Novel drug delivery systems
- Immunoglobulin administration techniques
- Long-term treatment efficacy
The investigator evaluates comparative effectiveness of different immunoglobulin delivery methods.
Clinical Therapeutics
The investigator studies novel biological therapeutics including efgartigimod formulations, focusing on long-term safety profiles and treatment optimization for autoimmune disorders.
- Biological therapy development
- Treatment safety assessment
- Therapeutic efficacy monitoring
Their work includes evaluation of innovative therapeutic formulations for enhanced patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.